BioInvent International AB (publ) (BOVNF)
USD 4.7
(0.0%)
USD 4.7
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -23.32 Million USD | 49.96% |
| 2022 | -46.61 Million USD | 52.02% |
| 2021 | -97.15 Million USD | -11.17% |
| 2020 | -87.38 Million USD | -466.33% |
| 2019 | -15.43 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -69.44 Million USD | -55.24% |
| 2024 Q2 | -451.14 Million SEK | -0.71% |
| 2024 Q1 | -41.83 Million SEK | -89.57% |
| 2023 Q4 | -23.32 Million USD | 55.02% |
| 2023 FY | -23.32 Million USD | 49.96% |
| 2023 Q3 | -51.85 Million USD | -2.63% |
| 2023 Q2 | -50.52 Million USD | -1.82% |
| 2023 Q1 | -49.62 Million USD | -6.46% |
| 2022 Q2 | -55.13 Million USD | 0.0% |
| 2022 FY | -46.61 Million USD | 52.02% |
| 2022 Q4 | -46.61 Million USD | 23.84% |
| 2022 Q3 | -61.19 Million USD | -11.0% |
| 2021 FY | -97.15 Million USD | -11.17% |
| 2020 FY | -87.38 Million USD | -466.33% |
| 2019 FY | -14.78 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 2118.575% |
| CSL Limited | 10.52 Billion USD | 100.222% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 247.962% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 666.369% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 5903.972% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 154.502% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | -269.944% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 2615.483% |
| Mesoblast Limited | 55.85 Million USD | 141.754% |
| Marizyme, Inc. | 18.56 Million USD | 225.603% |
| Genus plc | 190.6 Million USD | 112.237% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 1143.156% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 2021.364% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 3529.883% |
| ContraFect Corporation | -6.02 Million USD | -287.043% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 17422.771% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| IMV Inc. | 7.67 Million USD | 404.063% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 523.912% |
| MultiCell Technologies, Inc. | 90.04 USD | 25903259.707% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -3077.644% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 280.158% |
| EV Biologics, Inc. | 1.36 Million USD | 1804.949% |
| Q BioMed Inc. | 4.06 Million USD | 674.462% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 176.334% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 2414.462% |
| Biomind Labs Inc. | 711.4 Thousand USD | 3378.485% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 282.119% |
| Skye Bioscience, Inc. | -5.72 Million USD | -307.649% |
| SQZ Biotechnologies Company | -36.23 Million USD | 35.639% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 16782.788% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 512.919% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 1140.178% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 117496.713% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 3847.518% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 109.8 Million USD | 121.241% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 2811.241% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 1159.192% |
| GB Sciences, Inc. | 1.74 Million USD | 1434.802% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -12590.276% |
| argenx SE | -2.02 Billion USD | 98.85% |
| HST Global, Inc. | 96.79 Thousand USD | 24195.963% |
| Halberd Corporation | 144.72 Thousand USD | 16215.978% |
| Enzolytics Inc. | 981.65 Thousand USD | 2475.904% |
| Resverlogix Corp. | 6.45 Million USD | 461.544% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -3365.1% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 153.698% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 138.522% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 50.389% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 1266.515% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 429.844% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 6583.891% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 961.075% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | -163.84% |
| AVAX Technologies, Inc. | -5.9 Million USD | -295.094% |
| ONE Bio Corp. | 9.04 Million USD | 357.999% |
| Zenith Capital Corp. | 10.06 Thousand USD | 231848.857% |
| Genscript Biotech Corporation | -1.06 Billion USD | 97.802% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 11736.468% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 1077.488% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 14277.464% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -127223.971% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 11410.03% |
| Agentix Corp. | 37.63 Thousand USD | 62078.701% |
| Adynxx, Inc. | - USD | Infinity% |
| Kadimastem Ltd | -253.1 Thousand USD | -9114.943% |
| Helix BioMedix, Inc. | -2.57 Million USD | -807.506% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 215.029% |
| BioStem Technologies, Inc. | 4.47 Million USD | 621.537% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 11688.94% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -1780297.328% |
| LadRx Corporation | -2.03 Million USD | -1045.277% |
| Cell Source, Inc. | 9.23 Million USD | 352.635% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -114184.619% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 3771.98% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 3771.98% |
| NovAccess Global Inc. | 2.17 Million USD | 1170.626% |
| Affymax, Inc. | -5.59 Million USD | -316.709% |
| Itoco Inc. | 228.3 Thousand USD | 10315.81% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 17250.803% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 570.51% |
| CytoDyn Inc. | 20.26 Million USD | 215.108% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -3604723.029% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -251543.822% |
| Qrons Inc. | 351.42 Thousand USD | 6736.714% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 402.663% |
| SYBLEU INC | 473.71 Thousand USD | 5023.478% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -9243.484% |
| Rebus Holdings, Inc. | 305 Thousand USD | 7746.952% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 623.291% |
| Mobile Lads Corp. | 484.23 Thousand USD | 4916.535% |
| International Stem Cell Corporation | 2.59 Million USD | 1000.51% |
| Bioxytran, Inc. | 1.89 Million USD | 1328.239% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 37469.146% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 1169.43% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 779.185% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 372.69% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 3118.767% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -1765.856% |
| Neutra Corp. | 52.18 Thousand USD | 44791.599% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -837.051% |
| PureTech Health plc | -167.19 Million USD | 86.05% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -9423.252% |
| IXICO plc | -4.44 Million USD | -424.755% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 276.437% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 142.521% |
| CSL Limited | 10.52 Billion USD | 100.222% |
| Cellectis S.A. | -43.81 Million USD | 46.774% |